Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
To determine whether natural killer (NK) cells are the cells responsible for inhibition of outgrowth of Epstein-Barr virus (EBV)-infected autologous B lymphocytes, NK-enriched or NK-depleted populations were prepared by Percoll density gradient fractionation and complement lysis depletion of cells reacting with NK-specific monoclonal antibody HNK-1. These cells were then examined in parallel for NK activity and inhibition of outgrowth. NK-enriched low density cells inhibited outgrowth whereas NK-depleted high density cells did not. Low density cells treated with monoclonal antibodies HNK-1 and DR plus complement had little NK activity and failed to inhibit EBV-induced outgrowth, whereas these same cells treated with monoclonal antibodies OKT3 and DR plus complement had strong NK activity and caused marked inhibition of outgrowth. These findings indicate that NK cells rather than mature T cells, monocytes, or B cells, are responsible for inhibition of EBV-induced B cell outgrowth.